US Patent Litigations are now available. Check here

Explore Progenics Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jun 26, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3263571Aug 23, 2023Crystal Form Of (R)-N-Methylnaltrexone Bromide And Uses Thereof1